Elle, MD Biotechnologies has secured an equity investment of $100,000 from Invest Nova Scotia, matching the amount it received earlier this year from the New Brunswick Innovation Foundation.

Invest Nova Scotia, the provincial economic development and venture capital agency, announced the investment in a press release on Tuesday.

Based in New Minas, NS, and headed by Dr. Jennifer Johnston, the company focuses on enhancing reproductive autonomy by developing a safe, user-controlled contraceptive that’s free from pain, procedures, and hormones. Johnston, who founded the company in 2022, is a family physician and assistant professor at Dalhousie University School of Medicine.

“This investment will support Elle, MD Biotechnologies as it completes proof-of-concept preclinical safety and efficacy studies as well as biocompatibility and chemical testing,” said the Invest NS statement.

In June, NBIF invested $100,000 in Elle, MD after Johnston won the 2025 Fueling Female Founders Pitch Competition. First prize in the competition was a $100,000 investment from NBIF with a chance for a matching investment from Invest Nova Scotia.

Invest NS also said it has supported Elle, MD through its Accelerate Program and Early-Stage Commercialization Fund.